Loading...
Loading...
Browse all stories on DeepNewz
VisitDOJ Files 300-Page Lawsuit in Chicago Against Walgreens for Unlawful Opioid Prescriptions Since 2012
Jan 18, 2025, 02:17 AM
The U.S. Department of Justice has filed a 300-page lawsuit against Walgreens in the U.S. District Court in Chicago, accusing the pharmacy chain of filling millions of unlawful prescriptions for controlled substances, including opioids, from August 2012 to the present. The lawsuit alleges that Walgreens pharmacists filled prescriptions with clear red flags indicating they were likely unlawful, and that the company pressured its pharmacists to fill prescriptions quickly without verifying their validity. Walgreens is also accused of ignoring evidence from its own pharmacists and internal data that its stores were dispensing unlawful prescriptions. The company, which operates over 8,000 locations, has responded by stating it stands behind its pharmacists, who it claims fill legitimate prescriptions in accordance with all applicable laws and regulations. Walgreens is seeking court clarification on the responsibilities of pharmacies and pharmacists, arguing against what it calls arbitrary government rules. Following the lawsuit announcement, Walgreens stock sank. The DOJ filed a similar lawsuit against CVS in December.
View original story
Case dismissed • 25%
Settlement • 25%
Trial verdict in favor of DOJ • 25%
Trial verdict in favor of Walgreens • 25%
Case dismissed • 25%
Other outcome • 25%
CVS found guilty • 25%
CVS settles • 25%
CVS found liable • 25%
Ongoing litigation • 25%
Less than $1 billion • 25%
More than $5 billion • 25%
$1 billion to $5 billion • 25%
No penalty • 25%
CVS not liable • 25%
CVS settles • 25%
CVS found liable • 25%
Case dismissed • 25%
No sale • 25%
Sale completed • 25%
Sale abandoned • 25%
Sale to another party • 25%
Walmart • 25%
CVS • 25%
Rite Aid • 25%
Other • 25%
None of the above • 25%
Walmart • 25%
Rite Aid • 25%
Walgreens • 25%
CVS not found liable • 25%
Case dismissed • 25%
Settlement reached • 25%
CVS found liable • 25%
$10 billion to $15 billion • 25%
Below $5 billion • 25%
Above $15 billion • 25%
$5 billion to $10 billion • 25%
Minor financial penalties • 25%
No significant impact • 25%
Severe financial penalties • 25%
Major financial penalties • 25%
Other changes • 25%
No significant changes • 25%
New prescription verification policies • 25%
Increased pharmacist training • 25%